跳到主要导航 跳到搜索 跳到主要内容

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma

  • Qing Ma
  • , Yanmei Liu
  • , Liang Shang
  • , Jiao Yu
  • , Qiumin Qu
  • Xi'an Jiaotong University
  • Shaanxi Provincial People's Hospital
  • The First Affiliated Hospital of Xi’an Jiaotong University

科研成果: 期刊稿件 › 文章 › 同行评审

53 引用 (Scopus)

摘要

Accumulating evidence indicates that mitotic checkpoint serine/threonine kinase B (BUB1B) plays a critical role in multiple types of cancer. However, the biological function and molecular regulatory mechanism of BUB1B in glioblastoma (GBM) remain unclear. In the present study, we identified that BUB1B expression was enriched in GBM tumors and was functionally required for tumor proliferation both in vitro and in vivo. Clinically, BUB1B expression was associated with poor prognosis in GBM patients and BUB1B-dependent radioresistance in GBM was decreased by targeting BUB1B via shRNAs. Mechanistically, forkhead box protein M1 (FOXM1) transcriptionally regulated BUB1B expression by binding to and then activating the BUB1B promoter. Therapeutically, we found that FOXM1 inhibitor attenuated tumorigenesis and radioresistance of GBM both in vitro and in vivo. Altogether, BUB1B promotes tumor proliferation and induces radioresistance in GBM, indicating that BUB1B could be a potential therapeutic target for GBM.

源语言英语
页(从-至)3367-3375
页数9
期刊Oncology Reports
卷38
期6
DOI
出版状态已出版 - 12月 2017
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma' 的科研主题。它们共同构成独一无二的学术指纹。

引用此